Back to search

Netherlands· NL-694a5e29ac37

OLIMEL N9E, emulsie voor infusie

A lösungen zur parenteralen ernährung, kombinationen product containing acetaat (c2h3o2-) + alanine, (l-) + arginine, (l-) + asparaginezuur, (l-), registered in Netherlands by Baxter B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA10

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedOLIMEL N9E, emulsie voor infusieATCB05BA10REGISTER NO.NL-694a5e29ac37PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Lösungen zur parenteralen ernährung, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA10 (lösungen zur parenteralen ernährung, kombinationen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Lösungen zur parenteralen ernährung, kombinationen · ATC B05BA10

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ACETAAT (C2H3O2-) + ALANINE, (L-) + ARGININE, (L-) + ASPARAGINEZUUR, (L-)
Manufacturer
Baxter B.V.
Country
Netherlands (NL)
ATC code
B05BA10
ATC class
Lösungen zur parenteralen Ernährung, Kombinationen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    105713

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for lösungen zur parenteralen ernährung, kombinationen.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lösungen zur parenteralen ernährung, kombinationen · interactions on record

6 records

  • 2 severe
  • 4 moderate

Most severe, free to view

  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe
  • AmfetamineN06BA01moderate
  • DexamfetamineN06BA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/da152458-6c29-4c1e-b26c-c6fb3a54c63e
GET /v1/drugs/da152458-6c29-4c1e-b26c-c6fb3a54c63e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsie voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h105713_smpc.pdf",
  "strength": null,
  "atc_label": "Combinations",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg105713",
  "excipients": [
    "AZIJNZUUR (E 260), GECONCENTREERD",
    "EI FOSFATIDEN, GEZUIVERD",
    "GLYCEROL (E 422)",
    "NATRIUMHYDROXIDE (E 524)",
    "NATRIUMOLEAAT (E 470A)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "ACETAAT  (C2H3O2-)",
    "ALANINE, (L-)",
    "ARGININE, (L-)",
    "ASPARAGINEZUUR, (L-)",
    "CALCIUM (Ca2+)",
    "CALCIUMCHLORIDE 2-WATER (E 509)",
    "CHLORIDE (CL-)",
    "DINATRIUMGLYCEROFOSFAAT, GEHYDRATEERD",
    "FENYLALANINE, (L-)",
    "FOSFAAT (3-)",
    "GLUCOSE 1-WATER",
    "GLUTAMINEZUUR (L-) (+) (E 620)",
    "GLYCINE (E 640)",
    "HISTIDINE, (L-)",
    "ISOLEUCINE, (L-)",
    "KALIUM (K+)",
    "KALIUMCHLORIDE (E 508)",
    "LEUCINE, (L-) (E 641)",
    "LYSINEACETAAT, L-",
    "MAGNESIUM (MG2+)",
    "MAGNESIUMCHLORIDE 6-WATER (E 511)",
    "METHIONINE, (L-)",
    "NATRIUM (NA+)",
    "NATRIUMACETAAT 3-WATER (E 262)",
    "OLIJFOLIE",
    "PROLINE, (L-)",
    "SERINE, (L-)",
    "SOJAOLIE, GEZUIVERD",
    "THREONINE, (L-)",
    "TRYPTOFAAN, (L-)",
    "TYROSINE, (L-)",
    "VALINE, (L-)"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h105713.pdf",
  "authorised_at": "2010/07/27",
  "procedure_number": "FR/H/0419/005",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "105713",
  "additional_monitoring": "N"
}

See everything about lösungen zur parenteralen ernährung, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.